These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26884422)

  • 1. Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes.
    Ahn D; Pettus J; Edelman S
    J Diabetes Sci Technol; 2016 May; 10(3):793-8. PubMed ID: 26884422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial.
    Raghinaru D; Calhoun P; Bergenstal RM; Beck RW
    Diabetes Technol Ther; 2022 Dec; 24(12):868-872. PubMed ID: 35920822
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
    Wadwa RP; Laffel LM; Shah VN; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):395-402. PubMed ID: 29901421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring.
    Beck RW; Raghinaru D; Calhoun P; Bergenstal RM
    Diabetes Technol Ther; 2023 Mar; 25(3):157-160. PubMed ID: 36576488
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study.
    Garg SK; Voelmle MK; Beatson CR; Miller HA; Crew LB; Freson BJ; Hazenfield RM
    Diabetes Care; 2011 Mar; 34(3):574-9. PubMed ID: 21278138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inpatient Continuous Glucose Monitoring and Glycemic Outcomes.
    Levitt DL; Silver KD; Spanakis EK
    J Diabetes Sci Technol; 2017 Sep; 11(5):1028-1035. PubMed ID: 28290224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factory-Calibrated Continuous Glucose Monitoring: How and Why It Works, and the Dangers of Reuse Beyond Approved Duration of Wear.
    Forlenza GP; Kushner T; Messer LH; Wadwa RP; Sankaranarayanan S
    Diabetes Technol Ther; 2019 Apr; 21(4):222-229. PubMed ID: 30817171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
    Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
    J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring.
    Nally LM; Bondy N; Doiev J; Buckingham BA; Wilson DM
    Diabetes Technol Ther; 2019 Apr; 21(4):170-176. PubMed ID: 30839229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients.
    Price CE; Fanelli JE; Aloi JA; Anzola SC; Vishneski SR; Saha AK; Woody CC; Segal S
    J Clin Anesth; 2023 Aug; 87():111090. PubMed ID: 36913777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.
    Mauras N; Beck R; Xing D; Ruedy K; Buckingham B; Tansey M; White NH; Weinzimer SA; Tamborlane W; Kollman C;
    Diabetes Care; 2012 Feb; 35(2):204-10. PubMed ID: 22210571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes.
    Slattery D; Choudhary P
    Diabetes Technol Ther; 2017 May; 19(S2):S55-S61. PubMed ID: 28541131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor.
    Sanchez P; Ghosh-Dastidar S; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2019 Dec; 21(12):677-681. PubMed ID: 31385732
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.